Intermittent fasting reduces retinal acellular capillaries and oxidative stress in diabetic mouse models

The Finding

A preclinical review led by Ahmadzadeh et al. at the Faculty of Medicine found that various intermittent fasting regimens reduced retinal acellular capillaries and oxidative stress in diabetic mouse models. These benefits arose from improved metabolic function, enhanced mitochondrial health, and reduced inflammation within the retina.

How They Got There

The researchers conducted a preclinical review, synthesizing data from animal models exploring the effects of intermittent fasting on diabetic retinopathy. The study examined different intermittent fasting protocols, including alternate-day fasting, 5:2 dietary formulas, and time-restricted eating plans. Primary outcome variables included markers of retinal insulin and glucose metabolism, retinal mitophagy, mitochondrial function, oxidative stress, inflammation, and the formation of acellular capillaries within the retinas of db/db mice. The review also considered how intermittent fasting influenced retinal gut microbial and bile metabolite responses.

The Mechanism: What Happens Biologically

Intermittent fasting's observed benefits in diabetic retinas appear rooted in several biological pathways. It enhances retinal insulin and glucose metabolism, a critical factor for cell health. Furthermore, it improves retinal mitophagy—the selective degradation and recycling of damaged mitochondria—and boosts overall mitochondrial function. Concurrently, intermittent fasting reduces retinal oxidative stress and inflammation, key contributors to retinopathy progression. The review also highlighted alterations in retinal gut microbial and bile metabolite responses, suggesting a gut-eye axis in its protective effects.

Study Limitations

This review synthesizes findings exclusively from preclinical animal models, primarily db/db mice. Consequently, a significant limitation is the current lack of concrete human evidence directly linking intermittent fasting to specific eye responses in diabetic retinopathy. The findings, while promising, require validation through human clinical trials to confirm translatability to human physiology and disease progression.

Practical Application

Given that this study is a preclinical review focused solely on animal models, it is too early to apply these findings to a personal protocol for human retinal health or diabetic retinopathy. For these insights to become actionable for human performance optimization or health, robust randomized controlled human trials would be necessary. Such trials would need to investigate specific intermittent fasting protocols, measure relevant human retinal biomarkers and clinical outcomes, and establish safety and efficacy in human populations.

Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.